Gene expression profiling reveals multiple protective influences of the peptide alpha-melanocyte-stimulating hormone in experimental heart transplantation.
Colombo. Gualtiero G; Gatti. Stefano S; Turcatti. Flavia F; Sordi. Andrea A; Fassati. Luigi R LR; Bonino. Ferruccio F; Lipton. James M JM; Catania. Anna A
Key Findings
- NDP‑alpha‑MSH boosted expression of cytoskeleton proteins, kinases, transcription regulators, and protective enzymes early after transplant.
- The peptide suppressed immune and inflammatory gene pathways, as well as cell‑cycle and protein‑turnover signals.
- Later it reduced oxidative‑stress responses and increased ion‑channel, calcium‑handling, and metabolic gene activity.
Practical Outcomes
- For DIY health enthusiasts, the study suggests that alpha‑MSH has broad anti‑inflammatory and tissue‑protective effects, but it was tested only in rats undergoing organ transplants. There’s no dosage guidance or safety data for everyday use, so it’s not ready for self‑experimentation. The main takeaway is that the peptide might one day complement immunosuppressive drugs, but more human research is needed before any real‑world protocol can be recommended.
Summary
In a rat heart‑transplant model, a synthetic version of the peptide alpha‑melanocyte‑stimulating hormone (called NDP‑alpha‑MSH) helped the transplanted hearts survive longer by turning on genes that protect cells and turning off genes that drive inflammation and immune attack.
Abstract
Novel therapies are sought to increase efficiency and survival of transplanted organs. Previous research on experimental heart transplantation showed that treatment with the anti-inflammatory peptide alpha-melanocyte-stimulating hormone (alpha-MSH) prolongs allograft survival. The aim of the present research was to determine the molecular mechanism of this protective activity. Gene expression profile was examined in heart grafts removed on postoperative days 1 and 4 from rats treated with saline or the synthetic alpha-MSH analog Nle4DPhe7 (NDP)-alpha-MSH. On postoperative day 1, the peptide induced expression of cytoskeleton proteins, intracellular kinases, transcription regulators, metallopeptidases, and protease inhibitors. Conversely, NDP-alpha-MSH repressed immune, inflammatory, cell cycle, and protein turnover mediators. Later effects of alpha-MSH treatment included down-regulation of oxidative stress response and up-regulation of ion channels, calcium regulation proteins, phosphatidylinositol signaling system, and glycolipidic metabolism. NDP-alpha-MSH exerted its effects on both Ag-dependent and -independent injury. The results indicate that NDP-alpha-MSH preserves heart function through a broad effect on multiple pathways and suggest that the peptide could improve the outcome of organ transplantation in combination with immunosuppressive treatments.
Study Information
pubmed
2005
2005-09-01T00:00:00.000Z
10.4049/jimmunol.175.5.3391
21
56